ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
Ocean Biomedical Inc

Ocean Biomedical Inc (OCEA)

0.54
-0.034
(-5.92%)
終了 1月20日 6:00AM
0.5355
-0.0045
(-0.83%)
取引時間後: 9:50AM

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

主要統計と詳細

通貨
0.5355
買値
0.53
売値
0.749
出来高
108,526
0.5301 日の範囲 0.600399
0.4603 52 週間の範囲 7.79
時価総額
前日終値
0.574
始値
0.574
最終取引時間
財務取引量
US$ 59,279
VWAP
0.546217
平均取引量 (3 か月)
245,708
発行済株式数
34,868,628
配当利回り
-
PER
-3.03
1 株当たり利益 (EPS)
-3.28
歳入
-
純利益
-114.47M

Ocean Biomedical Inc について

Aesther Healthcare Acquisition Corp is a newly-organized blank check company. It is formed for the purpose effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. Aesther Healthcare Acquisition Corp is a newly-organized blank check company. It is formed for the purpose effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
本社
Dover, Delaware, USA
設立
-
Ocean Biomedical Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker OCEA. The last closing price for Ocean Biomedical was US$0.57. Over the last year, Ocean Biomedical shares have traded in a share price range of US$ 0.4603 to US$ 7.79.

Ocean Biomedical currently has 34,868,628 shares in issue. The market capitalisation of Ocean Biomedical is US$20.01 million. Ocean Biomedical has a price to earnings ratio (PE ratio) of -3.03.

OCEA 最新ニュース

Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

PROVIDENCE, Rhode Island, Nov. 22, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), today announced that on November 18, 2024, it received a notice from The Nasdaq Stock Market...

Ocean Biomedical, Inc. Announces Receipt of Nasdaq Staff Determination Letter

PROVIDENCE, Rhode Island, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), today announced that on October 16, 2024, it received a Staff Determination Letter from The...

Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Publication of New Data Deepening Understanding of Novel Cancer Immunotherapy Treatment Approach Targeting CHI3L1 and its Ability to Inhibit Anti-tumor and Related Tissue Remodeling Responses

Ocean Biomedical’s Anti-CHI3L1 patent coverage includes multiple methods of use for targeting a broad range of Cancers that include Lung Cancer, Glioblastoma, Prostate Cancer, Melanoma, and Breast...

Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Issued for PfGARP Malaria Antibodies Central to Company’s Malaria Treatment and Prevention Platforms

Providence, RI, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical (NASDAQ:OCEA) announced today that its Scientific Co-founder Dr. Jonathan Kurtis, MD, PhD, has been issued a key U.S. patent...

Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

PROVIDENCE, Rhode Island, Aug. 23, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), today announced that on August 19, 2024, it received a notice from The Nasdaq Stock Market LLC...

Ocean Biomedical (NASDAQ: OCEA) Congratulates Joint Venture Partner, Virion Therapeutics, on Positive Immunogenicity Results from Their Lead Checkpoint Modifier-Containing Immunotherapy, VRON-0200, for HBV Functional Cure, at EASL 2024

Providence, RI, June 05, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharma company working to accelerate the development of compelling discoveries from top research...

Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

PROVIDENCE, Rhode Island, May 30, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), today announced that on May 22, 2024, it received a notice from The Nasdaq Stock Market...

Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Allowance for Malaria Antibodies That Have Potential Capability to Protect Against Infection and Treat Severe Disease

Providence, RI, May 16, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical (NASDAQ:OCEA) announced today that Scientific Co-founder Dr. Jonathan Kurtis, MD, PhD, has been granted a new patent for his...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.1145-17.61538461540.650.70090.53551293990.6172534CS
4-0.0191-3.44392354850.55460.7534550.46037098340.6585549CS
12-0.4644-46.44464446440.99990.99990.46032457080.66839438CS
26-0.7145-57.161.251.450.46031442960.76914769CS
52-0.0598-10.04535528310.59537.790.460318206622.92951288CS
156-9.4245-94.62349397599.9626.59860.460315631914.66766429CS
260-9.4245-94.62349397599.9626.59860.460315631914.66766429CS

OCEA - Frequently Asked Questions (FAQ)

What is the current Ocean Biomedical share price?
The current share price of Ocean Biomedical is US$ 0.5355
How many Ocean Biomedical shares are in issue?
Ocean Biomedical has 34,868,628 shares in issue
What is the market cap of Ocean Biomedical?
The market capitalisation of Ocean Biomedical is USD 20.01M
What is the 1 year trading range for Ocean Biomedical share price?
Ocean Biomedical has traded in the range of US$ 0.4603 to US$ 7.79 during the past year
What is the PE ratio of Ocean Biomedical?
The price to earnings ratio of Ocean Biomedical is -3.03
What is the reporting currency for Ocean Biomedical?
Ocean Biomedical reports financial results in USD
What is the latest annual profit for Ocean Biomedical?
The latest annual profit of Ocean Biomedical is USD -114.47M
What is the registered address of Ocean Biomedical?
The registered address for Ocean Biomedical is 8 THE GREEN, STE A, KENT, DOVER, DELAWARE, 19901
What is the Ocean Biomedical website address?
The website address for Ocean Biomedical is www.aestherhealthcarespac.com
Which industry sector does Ocean Biomedical operate in?
Ocean Biomedical operates in the PHARMACEUTICAL PREPARATIONS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
BTCTBTC Digital Ltd
US$ 8.2697
(73.73%)
61.45M
BDMDBaird Medical Investment Holdings Ltd
US$ 8.80
(62.36%)
18.63M
CRKNCrown Electrokinetics Corporation
US$ 0.1235
(54.96%)
764.86M
NUKKNukkleus Inc
US$ 29.97
(45.98%)
19.09M
GSITGSI Technology
US$ 3.97
(44.36%)
87.7M
DOGZDogness International Corporation
US$ 18.23
(-58.77%)
740.45k
ORKTOrangeKloud Technology Inc
US$ 3.02
(-24.88%)
21.08M
PMAXPowell Max Ltd
US$ 0.6364
(-23.31%)
4.17M
LGCBLinkage Global Inc
US$ 0.2876
(-22.27%)
890.66k
YYAIConnexa Sports Technologies Inc
US$ 0.8299
(-20.20%)
602.48k
CRKNCrown Electrokinetics Corporation
US$ 0.1235
(54.96%)
764.86M
GCTKGlucoTrack Inc
US$ 0.0852
(15.45%)
465.22M
RIMEAlgorhythm Holdings Inc
US$ 0.0406
(-4.02%)
387.23M
TGLTreasure Global Inc
US$ 0.2459
(14.75%)
267.1M
NVDANVIDIA Corporation
US$ 137.71
(3.10%)
201.4M

OCEA Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock